Modulation of the effects of interleukin‐1 on glycosaminoglycan synthesis by the urine‐derived interleukin‐1 inhibitor, but not by interleukin‐6

Philippe Seckinger, Ilana Yaron, Frank A. Meyer, Michael Yaron, Jean‐Michel ‐M Dayer*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Interleukin‐1 (IL‐1) has been shown to regulate glycosaminoglycan (GAG) synthesis. We therefore investigated whether an IL‐1 inhibitor or IL‐6 modulates IL‐1 biologic activities in human synovial cells and cultured articular cartilage. We found that in the presence of a constant amount of IL‐1β, stimulation of hyaluronic acid (HA) synthesis by the IL‐1 inhibitor was inhibited in a dose‐dependent manner. Similarly, the decrease in sulfated GAG synthesis induced by IL‐1 was reversed by the addition of the IL‐1 inhibitor. In contrast, IL‐6 did not affect the production of HA, prostaglandin E2, or collagenase in synovial cells, nor did it affect GAG in organ cultures when tested in the presence or absence of IL‐1β. Hence, IL‐6 was ineffective in modulating IL‐1 bioactivities on HA or sulfated GAG synthesis. These results emphasize the importance of IL‐1 and IL‐1 inhibitor in connective tissue destruction and raise questions concerning the role of IL‐6 in this pathogenesis.

Original languageEnglish
Pages (from-to)1807-1814
Number of pages8
JournalArthritis and Rheumatology
Volume33
Issue number12
DOIs
StatePublished - Dec 1990
Externally publishedYes

Fingerprint

Dive into the research topics of 'Modulation of the effects of interleukin‐1 on glycosaminoglycan synthesis by the urine‐derived interleukin‐1 inhibitor, but not by interleukin‐6'. Together they form a unique fingerprint.

Cite this